Hyper IgM syndromes - PubMed (original) (raw)
Review
Hyper IgM syndromes
A Virginia Gulino et al. Curr Opin Rheumatol. 2003 Jul.
Abstract
The immune defense against extracellular pathogens is largely dependent on antibody production. Class switch recombination and somatic hypermutation shape the secondary antibody repertoire in peripheral lymphoid tissue. In the past few years, a series of primary immune deficiencies characterized by defects in these processes and collectively referred to as hyper-IgM syndromes, have been described. Careful investigation of these rare "experiments of nature" has enabled to identify novel genes and molecular events that drive terminal B-cell differentiation. Abnormalities in these genes are likely involved also in lymphoid tumorigenesis and autoimmunity.
Similar articles
- Hyper-IgM syndromes: a model for studying the regulation of class switch recombination and somatic hypermutation generation.
Durandy A. Durandy A. Biochem Soc Trans. 2002 Aug;30(4):815-8. doi: 10.1042/bst0300815. Biochem Soc Trans. 2002. PMID: 12196205 Review. - Human genetic defects in class-switch recombination (hyper-IgM syndromes).
Durandy A, Honjo T. Durandy A, et al. Curr Opin Immunol. 2001 Oct;13(5):543-8. doi: 10.1016/s0952-7915(00)00256-9. Curr Opin Immunol. 2001. PMID: 11544001 Review. - Hyper-IgM syndromes.
Durandy A, Peron S, Fischer A. Durandy A, et al. Curr Opin Rheumatol. 2006 Jul;18(4):369-76. doi: 10.1097/01.bor.0000231905.12172.b5. Curr Opin Rheumatol. 2006. PMID: 16763457 Review. - Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2.
Imai K, Zhu Y, Revy P, Morio T, Mizutani S, Fischer A, Nonoyama S, Durandy A. Imai K, et al. Clin Immunol. 2005 Jun;115(3):277-85. doi: 10.1016/j.clim.2005.02.003. Clin Immunol. 2005. PMID: 15893695 - Defects of class-switch recombination.
Notarangelo LD, Lanzi G, Peron S, Durandy A. Notarangelo LD, et al. J Allergy Clin Immunol. 2006 Apr;117(4):855-64. doi: 10.1016/j.jaci.2006.01.043. J Allergy Clin Immunol. 2006. PMID: 16630945 Review.
Cited by
- Genetic and hormonal factors in female-biased autoimmunity.
Rubtsov AV, Rubtsova K, Kappler JW, Marrack P. Rubtsov AV, et al. Autoimmun Rev. 2010 May;9(7):494-8. doi: 10.1016/j.autrev.2010.02.008. Epub 2010 Feb 6. Autoimmun Rev. 2010. PMID: 20144912 Free PMC article. Review. - Autoimmunity in hyper-IgM syndrome.
Jesus AA, Duarte AJ, Oliveira JB. Jesus AA, et al. J Clin Immunol. 2008 May;28 Suppl 1:S62-6. doi: 10.1007/s10875-008-9171-x. Epub 2008 Feb 2. J Clin Immunol. 2008. PMID: 18246414 Review. - TACI and BAFF-R mediate isotype switching in B cells.
Castigli E, Wilson SA, Scott S, Dedeoglu F, Xu S, Lam KP, Bram RJ, Jabara H, Geha RS. Castigli E, et al. J Exp Med. 2005 Jan 3;201(1):35-9. doi: 10.1084/jem.20032000. J Exp Med. 2005. PMID: 15630136 Free PMC article. - Comprehensive review of autoantibodies in patients with hyper-IgM syndrome.
Barbouche MR, Chen Q, Carbone M, Ben-Mustapha I, Shums Z, Trifa M, Malinverno F, Bernuzzi F, Zhang H, Agrebi N, Norman GL, Chang C, Gershwin ME, Invernizzi P. Barbouche MR, et al. Cell Mol Immunol. 2018 Jun;15(6):610-617. doi: 10.1038/cmi.2017.140. Epub 2018 Feb 5. Cell Mol Immunol. 2018. PMID: 29400703 Free PMC article. Review. - Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans.
Meyers G, Ng YS, Bannock JM, Lavoie A, Walter JE, Notarangelo LD, Kilic SS, Aksu G, Debré M, Rieux-Laucat F, Conley ME, Cunningham-Rundles C, Durandy A, Meffre E. Meyers G, et al. Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11554-9. doi: 10.1073/pnas.1102600108. Epub 2011 Jun 23. Proc Natl Acad Sci U S A. 2011. PMID: 21700883 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous